SIBN Stock Overview
A medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
SI-BONE, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$13.25 |
| 52 Week High | US$21.70 |
| 52 Week Low | US$11.70 |
| Beta | 1.18 |
| 1 Month Change | 5.49% |
| 3 Month Change | -10.77% |
| 1 Year Change | -36.96% |
| 3 Year Change | -39.44% |
| 5 Year Change | -37.29% |
| Change since IPO | -33.95% |
Recent News & Updates
Market Cool On SI-BONE, Inc.'s (NASDAQ:SIBN) Revenues
Nov 04
Is SI-BONE (NASDAQ:SIBN) Using Too Much Debt?
Sep 25Recent updates
Market Cool On SI-BONE, Inc.'s (NASDAQ:SIBN) Revenues
Nov 04Is SI-BONE (NASDAQ:SIBN) Using Too Much Debt?
Sep 25SI-BONE, Inc.'s (NASDAQ:SIBN) P/S Is On The Mark
Apr 01Analyst Estimates: Here's What Brokers Think Of SI-BONE, Inc. (NASDAQ:SIBN) After Its Full-Year Report
Feb 29Is SI-BONE (NASDAQ:SIBN) Using Debt In A Risky Way?
Feb 28Is SI-BONE (NASDAQ:SIBN) Using Too Much Debt?
Nov 12Is SI-BONE (NASDAQ:SIBN) Using Too Much Debt?
Aug 09Is SI-BONE (NASDAQ:SIBN) A Risky Investment?
Apr 20Is SI-BONE (NASDAQ:SIBN) Using Debt In A Risky Way?
Jan 01Is SI-BONE (NASDAQ:SIBN) Using Debt In A Risky Way?
Sep 24SI-BONE (NASDAQ:SIBN) Has Debt But No Earnings; Should You Worry?
Apr 19Is SI-BONE (NASDAQ:SIBN) Using Debt In A Risky Way?
Jan 05Is SI-BONE (NASDAQ:SIBN) Using Debt In A Risky Way?
Oct 05Shareholder Returns
| SIBN | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -1.3% | -1.5% | -2.4% |
| 1Y | -37.0% | 10.0% | 23.4% |
Return vs Industry: SIBN underperformed the US Medical Equipment industry which returned 10.1% over the past year.
Return vs Market: SIBN underperformed the US Market which returned 23.3% over the past year.
Price Volatility
| SIBN volatility | |
|---|---|
| SIBN Average Weekly Movement | 8.8% |
| Medical Equipment Industry Average Movement | 7.6% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: SIBN has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: SIBN's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | 344 | Laura Francis | si-bone.com |
SI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion.
SI-BONE, Inc. Fundamentals Summary
| SIBN fundamental statistics | |
|---|---|
| Market cap | US$555.68m |
| Earnings (TTM) | -US$37.40m |
| Revenue (TTM) | US$157.04m |
3.5x
P/S Ratio-14.9x
P/E RatioIs SIBN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SIBN income statement (TTM) | |
|---|---|
| Revenue | US$157.04m |
| Cost of Revenue | US$35.02m |
| Gross Profit | US$122.02m |
| Other Expenses | US$159.42m |
| Earnings | -US$37.40m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.89 |
| Gross Margin | 77.70% |
| Net Profit Margin | -23.82% |
| Debt/Equity Ratio | 21.9% |
How did SIBN perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 05:02 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
SI-BONE, Inc. is covered by 15 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Craig Bijou | BofA Global Research |
| Caitlin Cronin | Canaccord Genuity |
| William Plovanic | Canaccord Genuity |